Condition: Head and Neck Cancer · Sponsor: UNC Lineberger Comprehensive Cancer Center
Radiation-induced xerostomia (dry mouth) is one of the most common and severe side effects for patients receiving radiation therapy for head and neck cancer. New approaches are needed to reduce this side effect and improve patients' quality of life after treatment. This is a Phase II, single-center, double-masked, parallel-arm, randomized controlled trial. It compares MRI-guided parotid ductal sparing to the standard approach of mean parotid gland sparing, focusing on patient-reported dry mouth outcomes in individuals receiving definitive radiotherapy for oropharyngeal cancer.
This description comes directly from the study's public registry record.
Tuvara King · (984) 974-0000 · tjking@med.unc.edu
Melissa Knutsen · (984) 974-0000 · Melissa_Knutsen@med.unc.edu
Always discuss trial participation with your own doctor first.
| University of North Carolina at Chapel Hill, Department of Radiation Oncology | Chapel Hill, North Carolina, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07278557